Operating under strict NABL ISO/IEC 17025:2017 accreditation, CDSCO approvals, DCA licensing, OECD GLP compliance, and ALCOA+ electronic data integrity guidelines.
Formally accredited testing laboratory scope covering chemical, biological, and microbiological testing of pharmaceuticals, APIs, and medical devices.
Approved by the Central Drugs Standard Control Organization (CDSCO) and State Drug Control Administration (DCA) under Form 37 for commercial release testing.
Adherence to OECD Principles of Good Laboratory Practice (GLP) ensuring mutual acceptance of preclinical safety data worldwide.
All analytical CDS instruments (Empower/LabSolutions) feature automated audit trails, role-based user privileges, and secure electronic signatures.
Strict current Good Manufacturing Practices (cGMP) in line with WHO, ICH Q7, and Schedule M standards for pharmaceutical QC batch release.
Robust Quality Management System covering Change Control, CAPA, OOS/OOT investigations, calibration, and vendor qualification.
